The Relationship Between Obesity Paradox and Inflammation Markers in STEMI Short: Obesity Paradox in STEMI
Open Access
- 1 April 2025
- journal article
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 28 (1) , 13-17
Abstract
Objectives: Inflammation plays a very important role in the pathogenesis of coronary artery disease (CAD) and its prognosis. Especially; C-reactive protein (CRP) is associated with poor prognosis in patients with CAD. In this study, the relationship between CRP levels and body mass ındex (BMI) was investigated in patients who underwent primary coronary intervention (PCI) due to ST elevation myocardial infarction (STEMI). Methods: Between January 2015 and February 2016, 132 patients who underwent PCI due to acute STEMI were included in the retrospective study. Patients were classified into two groups: (Group 1: BMI 35 kg/m2 n=9, total: 36 patients; Group 2: 25 2 n=58 and 30 <BMI BMI <35. Whereas, it was significantly higher in STEMI patients with 25 35. One of the reasons for the better prognosis of mildly overweight and Class 1 obese patients with STEMI diagnosis may be the low values of CRP which has many effects on atherosclerotic plaque formation.Keywords
This publication has 29 references indexed in Scilit:
- Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting StentsJACC: Cardiovascular Interventions, 2018
- The Relationship of Body Mass Index to Percutaneous Coronary Intervention OutcomesJACC: Cardiovascular Interventions, 2017
- The Interaction of Cardiorespiratory Fitness With Obesity and the Obesity Paradox in Cardiovascular DiseaseProgress in Cardiovascular Diseases, 2017
- Prevalence of obesity and severe obesity in US children, 1999‐2014Obesity, 2016
- Obesity and Prevalence of Cardiovascular Diseases and Prognosis—The Obesity Paradox UpdatedProgress in Cardiovascular Diseases, 2016
- The obesity paradox in acute coronary syndrome: a meta-analysisEuropean Journal of Epidemiology, 2014
- Body Mass Index and Acute and Long-Term Outcomes After Acute Myocardial Infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial)The American Journal of Cardiology, 2014
- Impact of Body Weight and Extreme Obesity on the Presentation, Treatment, and In-Hospital Outcomes of 50,149 Patients With ST-Segment Elevation Myocardial InfarctionJACC, 2011
- Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)—Can C-Reactive Protein Be Used to Target Statin Therapy in Primary Prevention?The American Journal of Cardiology, 2006
- Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarctionThe American Journal of Medicine, 2003